7.47 (-%)
As of Nov 29, 2024
Source:
Kezar Life Sciences, Inc. is a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. We believe therapies that inhibit multiple drivers of disease by targeting fundamental upstream control processes within the cell have the potential for profound therapeutic benefit in a number of difficult-to-treat diseases.
Country | United States |
Headquarters | south san francisco, california |
Phone Number | (650) 822-5600 |
Industry | manufacturing |
CEO | Christopher Kirk, Ph.D. |
Website | www.kezarlifesciences.com |